Pimobendan for African Grey Parrots: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Pimobendan is a prescription heart medication that helps the heart pump more effectively while also relaxing blood vessels. In veterinary medicine, it is best known for use in dogs, but avian vets may also use it extra-label in parrots when heart disease is suspected or confirmed. That means the drug is not specifically labeled for African Grey parrots, yet your vet may prescribe it when the expected benefit outweighs the risks.

African Grey parrots can develop cardiovascular disease, including cardiomyopathy, atherosclerosis, and congestive heart failure. Published avian literature shows that heart disease is clinically important in parrots, and African Greys are one of the species in which heart disease is regularly discussed. Because birds have fast heart rates and can hide illness until they are quite sick, medications like pimobendan are usually only one part of a larger treatment and monitoring plan.

In parrots, pimobendan is generally used to improve cardiac output and support circulation. It is not a cure for underlying heart disease. Instead, it may help some birds breathe easier, tolerate activity better, and feel more comfortable when used alongside diagnostics, follow-up exams, and other medications chosen by your vet.

Avian vets most often consider pimobendan for parrots with congestive heart failure, cardiomyopathy, or other conditions where the heart is not pumping efficiently. In practice, it may be paired with drugs such as diuretics when a bird has fluid buildup, breathing effort, weakness, exercise intolerance, or imaging changes that suggest heart enlargement or poor cardiac function.

For African Grey parrots, your vet may discuss pimobendan if there are signs such as tail bobbing with breathing, open-mouth breathing, reduced stamina, abdominal distension, faintness, or imaging findings consistent with heart disease. It may also be considered after ultrasound or radiographic evaluation suggests reduced contractility or chamber enlargement.

Pimobendan is not appropriate for every bird with a heart murmur or every bird that seems tired. Some parrots need more diagnostics before medication starts, and some may need different medications depending on whether the main problem is fluid overload, arrhythmia, vascular disease, or another illness that looks like heart disease. Your vet will decide whether pimobendan fits the overall picture.

Pimobendan dosing in African Grey parrots should be set by an avian veterinarian. A commonly cited empirical avian dose in parrots is 0.25 mg/kg by mouth every 12 hours, based on published avian pharmacokinetic work and clinical use in parrots. However, that does not mean every African Grey should receive that exact dose. Species differences, body condition, severity of heart disease, concurrent medications, and the formulation used can all change the plan.

One published pharmacokinetic study in Hispaniolan Amazon parrots noted that birds had previously been treated at an empirical dosage of 0.25 mg/kg every 12 hours, but the study also emphasized that more work is needed to define ideal avian dosing. In other words, avian dosing is still evolving. Your vet may adjust the amount, interval, or formulation based on response and tolerance.

Because African Greys are small patients, dosing errors matter. Never split or compound tablets on your own unless your vet specifically instructs you to do so. Many parrots need a compounded preparation or carefully measured tiny dose. Give the medication exactly as prescribed, and ask your vet what to do if a dose is missed. If your bird becomes weak, more distressed, or stops eating after a dose, contact your vet promptly.

Side effects reported with pimobendan in veterinary patients include poor appetite, lethargy, diarrhea, weakness, incoordination, and worsening breathing signs. In parrots, published safety data are much more limited than in dogs, so avian vets rely on careful monitoring and follow-up rather than assuming a bird will respond the same way a dog does.

For an African Grey parrot, watch for decreased appetite, fluffed posture, unusual quietness, falling from the perch, vomiting or regurgitation, loose droppings, increased breathing effort, or new weakness after starting the medication. Birds can decline quickly, so subtle changes matter. If your parrot seems more tired than expected or has trouble perching, call your vet the same day.

See your vet immediately if your bird has open-mouth breathing, marked tail bobbing, collapse, severe weakness, blue or dusky skin around the face, or cannot stay upright. Those signs may reflect progression of heart disease, a medication problem, or another emergency that needs urgent avian care.

Pimobendan can interact with other medications, which is one reason your vet should review every prescription, supplement, and over-the-counter product your bird receives. In veterinary references, pimobendan may interact with other highly protein-bound drugs, and it may have additive or competing effects with other phosphodiesterase inhibitors such as sildenafil, pentoxifylline, or theophylline.

Absorption may also be reduced when pimobendan is given with medications that raise stomach pH, including proton pump inhibitors such as omeprazole, esomeprazole, or pantoprazole. In birds, this matters even more because small dose changes can have a larger clinical effect. If your African Grey is on multiple heart, respiratory, or GI medications, your vet may need to stagger doses or change the plan.

Do not start, stop, or combine heart medications on your own. African Greys with heart disease are often on more than one drug, and the safest plan depends on the exact diagnosis, imaging findings, and how your bird is doing at home.